GLP-1 Drug Shortages and Compounding July 2024 IPD has released a new podcast episode, GLP-1 Drug Shortages and Compounding," where Alyssa Guest, PharmD, discusses the glucagon-like peptide-1 (GLP-1) drugs and how interest in weight loss, viral social media posts, celebrity endorsements, illegitimate compounding, and drug shortages have all impacted access to GLP-1s
225 Body recomposition the process of building muscle and losing fat simultaneously is one of the most contested concepts in the entire fitness industry
This group includes flavonoids, phenolic acids, and tannins, which are widely recognized for their antioxidant capacity
Eloralintide (LY3841136): A Selective Amylin Receptor Agonist Eli Lilly also shared Phase 1 data on Eloralintide (LY3841136), a selective amylin receptor agonist that mimics the natural hormone amylin to regulate appetite and blood glucose
Medicare introduced the GLP-1 Bridge program on July 1, 2026, covering Wegovy, Zepbound (KwikPen only), and Foundayo at $50/month through December 31, 2027